Roberto Pedro Rosenkranz's most recent trade in FibroGen Inc was a trade of 12,000 Common Stock done at an average price of $28.7 . Disclosure was reported to the exchange on June 9, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
FibroGen Inc | Roberto Pedro Rosenkranz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.65 per share. | 09 Jun 2020 | 12,000 | 84,100 (0%) | 0% | 28.7 | 343,800 | Common Stock |
FibroGen Inc | Roberto Pedro Rosenkranz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2020 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Roberto Pedro Rosenkranz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2020 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Roberto Pedro Rosenkranz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.05 per share. | 09 Jun 2020 | 12,000 | 96,100 (0%) | 0% | 19.1 | 228,600 | Common Stock |
FibroGen Inc | Roberto Pedro Rosenkranz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Roberto Pedro Rosenkranz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 4,700 | 72,100 (0%) | 0% | 0 | Common Stock |